Updated on 13 October 2026
Advanced LNP & Nanomedicine Evaluation
Head of institute HEALTH at Joanneum Research Forschungsges. mbH
Graz, Austria
About
JOANNEUM RESEARCH HEALTH accelerates the development of innovative nanomedicines by providing specialized solutions for the preclinical evaluation, bioanalysis, and in-vivo tracking of Lipid Nanoparticles (LNPs). We help biotech partners optimize formulation performance and validate tissue-specific delivery.
Core Services & Applications
• In-Vivo Biodistribution & Tissue Targeting: Quantitative tracking of LNPs in specific target tissues (e.g., brain, skin, adipose tissue) utilizing our proprietary Open Flow Microperfusion (OFM) technology.
• Blood-Brain Barrier (BBB) Penetration: Utilizing cOFM to directly measure the efficiency of surface-engineered LNPs in crossing the intact blood-brain barrier into the interstitial fluid of the brain.
• High-End Lipid Analytics: GLP-compliant quantification of individual lipid components (e.g., ionizable lipids, helper lipids, cholesterol, and PEG-lipids) in biological matrices using advanced LC-MS/MS.
• Cargo-Agnostic PK/PD Profiling: Simultaneous monitoring of vehicle stability and active ingredient release directly at the site of action.
Organisation
Similar opportunities
Service
Franz Feichtner
Head of institute HEALTH at Joanneum Research Forschungsges. mbH
Graz, Austria
Service
Subcutaneous Drug Delivery & mAb Evaluation
Franz Feichtner
Head of institute HEALTH at Joanneum Research Forschungsges. mbH
Graz, Austria
Service
GLP compliant bio and pharmaceutical analysis
Franz Feichtner
Head of institute HEALTH at Joanneum Research Forschungsges. mbH
Graz, Austria